Objective The efficacy of growth hormone (GH) co-treatment within a GnRH agonist long
regimen, in women with a normal ovarian response to controlled ovarian hyperstimulation …

Objective The efficacy of growth hormone co-stimulation to long luteal GnRHa regimen in
poor responders to COH for IVF was assessed. Methods This prospective, randomized …

BACKGROUND Whether the addition of growth hormone (GH) can improve the probability of
pregnancy in poor responders undergoing ovarian stimulation for in-vitro fertilization (IVF) …

Objective Growth hormone (GH) acts in both early and late follicular development to
stimulate the proliferation and differentiation of granulosa cells and to increase the …

To investigate the clinical efficacy of growth hormone (GH) in normal response patients with
poor embryo quality in previous in vitro fertilization cycles. A total of 1562 infertile women …

The aim of this prospective observational study is to determine the different outcomes of
IVF/ICSI treatments after using antagonists or agonists of gonadotrophin-releasing hormone …

We aim to assess the in vitro fertilization-embryo transfer (IVF-ET) outcome in patients
receiving an extremely high 450 daily dose (IU) of gonadotropins during controlled ovarian …

Purpose To determine the effect of human growth hormone (GH) supplementation during
ovarian stimulation in women undergoing IVF/PGT-A cycles, who do not meet the Bologna …

Purpose Supplementation of growth hormone (GH) during controlled ovarian stimulation
(COS) has been suggested to improve ovarian response. Despite potential benefits in poor …

[Do poor-responder patients benefit from increasing the daily gonadotropin dose from 300 to
450 IU during controlled ovarian hyperstimulation for IVF?]. - Abstract - Europe PMC Sign in …